These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 3099684

  • 1. [Injectable and oral propafenone in nodal reentry and pathways of ventricular preexcitation].
    Fauchier JP, Cosnay P, Moquet B, Rouesnel P, Kapusta P, Vrancea F.
    Arch Mal Coeur Vaiss; 1986 Sep; 79(10):1506-14. PubMed ID: 3099684
    [Abstract] [Full Text] [Related]

  • 2. [Injectable and oral cibenzoline in the treatment of supraventricular tachycardia related to intranodal reentry or accessory atrioventricular conduction pathway].
    Fauchier JP, Rouesnel P, Breuillac JC, Cosnay P, Scheck F, Garnier LF.
    Ann Cardiol Angeiol (Paris); 1994 Apr; 43(4):194-203. PubMed ID: 8024234
    [Abstract] [Full Text] [Related]

  • 3. Electrophysiologic effects of oral propafenone in Wolff-Parkinson-White syndrome studied by programmed electrical stimulation.
    Sethi KK, Prasad GS, Mohan JC, Arora R, Khalilullah M.
    Indian Heart J; 1991 Apr; 43(1):5-10. PubMed ID: 1894303
    [Abstract] [Full Text] [Related]

  • 4. [Effects of oral and injectable flecainide in patients with an accessory atrioventricular pathway].
    Fauchier JP, Cosnay P, Rouesnel P, Moquet B, Bonnet P, Scala PJ, Demeyer JF.
    Arch Mal Coeur Vaiss; 1985 Oct; 78 Spec No():81-90. PubMed ID: 3938264
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [The study of acute clinical electrophysiological effects of propafenone on paroxysmal supraventricular tachycardia using transesophageal atrial pacing technique].
    Li Q, Wang Z, Peng D.
    Hunan Yi Ke Da Xue Xue Bao; 1997 Oct; 22(2):123-6. PubMed ID: 9868052
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Accessory pathway reciprocating tachycardia.
    Obel OA, Camm AJ.
    Eur Heart J; 1998 May; 19 Suppl E():E13-24, E50-1. PubMed ID: 9717020
    [Abstract] [Full Text] [Related]

  • 12. [Electrophysiologic effects of penticainide in patients with supraventricular tachycardia].
    Kühlkamp V, Mewis C, Mayer F, Seipel L.
    Z Kardiol; 1990 Oct; 79(10):725-31. PubMed ID: 2087860
    [Abstract] [Full Text] [Related]

  • 13. Usefulness of programmed stimulation in predicting efficacy of propafenone in long-term antiarrhythmic therapy for paroxysmal supraventricular tachycardia.
    Manz M, Steinbeck G, Lüderitz B.
    Am J Cardiol; 1985 Oct 01; 56(10):593-7. PubMed ID: 4050693
    [Abstract] [Full Text] [Related]

  • 14. [Electrophysiologic effects of intravenous propafenone].
    Zhang S, Sun RL, Song YC.
    Zhonghua Xin Xue Guan Bing Za Zhi; 1989 Jun 01; 17(3):133-6, 189. PubMed ID: 2598779
    [Abstract] [Full Text] [Related]

  • 15. [Use of transesophageal left atrial cardiac pacing for assessment of cordarone effectiveness in patients with atrioventricular tachycardia].
    Matiushin GV, Shul'man VA, Balog AI, Golovenkin SE, Bezruk AP, Ivanitskiĭ EA, Smirnova OV.
    Ter Arkh; 1998 Jun 01; 70(6):47-50. PubMed ID: 9695227
    [Abstract] [Full Text] [Related]

  • 16. Use of intracardiac recordings to determine the site of drug action in paroxysmal supraventricular tachycardia.
    Jackman WM, Friday KJ, Fitzgerald DM, Yeung-Lai-Wah JA, Lazzara R.
    Am J Cardiol; 1988 Dec 20; 62(19):8L-19L. PubMed ID: 3059792
    [Abstract] [Full Text] [Related]

  • 17. Unusual induction of slow-fast atrioventricular nodal reentrant tachycardia. Report of two cases.
    Calò L, Riccardi R, Scaglione M, Caponi D, Golia P, Gaita F.
    G Ital Cardiol; 1999 Nov 20; 29(11):1318-22. PubMed ID: 10609133
    [Abstract] [Full Text] [Related]

  • 18. [Anti-arrhythmic effects of intravenous magnesium sulfate in paroxysmal supraventricular tachycardia].
    Etienne Y, Blanc JJ, Boschat J, Le Potier J, Jobic Y, Le Grand O, Penther P.
    Ann Cardiol Angeiol (Paris); 1988 Nov 20; 37(9):535-8. PubMed ID: 3223727
    [Abstract] [Full Text] [Related]

  • 19. [Electrophysiologic effects of diprafenone in supraventricular and ventricular tachycardia].
    Manz M, Beermann J, Gerckens U, Lüderitz B.
    Z Kardiol; 1986 Dec 20; 75(12):757-63. PubMed ID: 3825226
    [Abstract] [Full Text] [Related]

  • 20. [Electrophysiologic effect of a new Ca(2+)-antagonist, TA-3090 on supraventricular tachycardia and conduction system].
    Tanno K, Kobayashi Y, Miyata A, Chiyoda K, Nakagawa H, Kurano K, Kikushima S, Yazawa T, Baba T, Mukai H.
    Kokyu To Junkan; 1992 Sep 20; 40(9):897-902. PubMed ID: 1439290
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.